Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 as against Rs 23.68 crore during the previous quarter ended September 2023. Sales rose 10.60% to Rs 87.11 crore in the quarter ended September 2024 as against Rs 78.76 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	87.11	78.76	11
OPM %	20.63	21.47	-
PBDT	28.15	33.08	-15
PBT	27.56	32.43	-15
NP	20.41	23.68	-14